Home/Filings/4/0001615219-22-000008
4//SEC Filing

Arthur David J. 4

Accession 0001615219-22-000008

CIK 0001615219other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 4:08 PM ET

Size

5.4 KB

Accession

0001615219-22-000008

Insider Transaction Report

Form 4
Period: 2022-01-20
Arthur David J.
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-01-20+500,000500,000 total
    Exercise: $0.48Exp: 2032-01-19Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]25% of the options are fully vested on January 19, 2023, and 1/36 of the remaining options vest on each monthly anniversary thereafter.

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001769331

Filing Metadata

Form type
4
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:08 PM ET
Size
5.4 KB